Written and maintained by CASRAI Editorial Board
Published
This page describes products and general use; it is not medical advice.
On this page
A Permcath is the common clinical name for a long-term, cuffed hemodialysis catheter: a soft tube placed through the skin into a large vein so that blood can be taken to and returned from a dialysis machine. It is used by people who need hemodialysis, and it is handled by dialysis nurses, vascular access teams, clinic staff and supply buyers. This guide explains what the term means, how the device is classified by the FDA, which sizes one manufacturer lists, how a catheter compares with a fistula or graft, and how it differs from a peritoneal dialysis catheter.
What is a Permcath?
“Permcath” (also spelled “permacath”) is a clinical shorthand rather than a regulatory category. Published case reports use it for a tunnelled hemodialysis catheter placed in a neck vein, for example a “tunneled right internal jugular Permcath” (Cureus case report, PMID 37425584). The FDA does not use the word. Under 21 CFR 876.5540, the relevant device is a blood access device “intended to provide access to a patient’s blood for hemodialysis or other chronic uses”. The regulation defines an implanted blood access device as a prescription device that is surgically placed and intended to remain in the body for 30 days or more, and it lists catheters “with cuff(s)” among the examples. A nonimplanted device stays in for less than 30 days (read 2026-11-07).
In practice, then, a Permcath belongs to the long-term, cuffed group, while a short-term “vascath” belongs to the temporary group. See vascath for the non-tunnelled type and what is a hemodialysis catheter for the FDA classification in more detail.
Which catheter is used in hemodialysis?
Hemodialysis can use three kinds of vascular access: a fistula, a graft or a catheter. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes a catheter as a soft tube placed in a vein in the neck, chest or leg near the groin, and calls it a temporary access, used when kidney disease progresses quickly or no access was made beforehand (read 2026-11-07). Long-term cuffed catheters, the group Permcath refers to, are the catheter option intended to stay in for 30 days or more under the FDA definition above. Peritoneal dialysis uses a different tube entirely (see below).
Permcath, vascath and Quinton: what the sources support
| Term | What it refers to | Source |
|---|---|---|
| Permcath / permacath | Name used in clinical literature for a tunnelled, cuffed hemodialysis catheter intended for long-term use | PMID 37425584; PMID 38500070; 21 CFR 876.5540 |
| Vascath | Non-tunnelled hemodialysis catheter for short-term access (see the vascath guide) | 21 CFR 876.5540 (nonimplanted, under 30 days) |
| Implanted blood access device (FDA term) | Prescription device, surgically placed, intended to remain 30 days or more; examples include catheters with cuff(s) | 21 CFR 876.5540 |
What is the difference between a Quinton catheter and a Permacath?
Both names are used informally for long-term dialysis catheters, and the FDA regulation classifies the device by function and duration, not by brand name. Any design differences between particular products, such as tip shape, lumen size or cuff material, are stated in each manufacturer’s instructions for use, so compare products using those documents rather than the informal name.
Sizes: one manufacturer’s published range
Catheters are sized by diameter in French (F) and by length in centimetres. As one example, not a recommendation, BD lists its GlidePath long-term hemodialysis catheters, indicated for “short-term or long-term vascular access for hemodialysis”, in the following configurations (BD product page, read 2026-11-07):
| Diameter | Configuration | Listed lengths (cm) |
|---|---|---|
| 13F | Straight | 15, 19, 23, 27, 31, 35 |
| 14.5F | Straight | 15, 19, 23, 27, 31, 35, 42, 50 |
| 14.5F | AlphaCurve | 19, 24, 28, 31 |
BD describes a symmetric tip design for this family. Sizes and features differ by product, so the instructions for use for the specific catheter are the reference.
Catheter, fistula or graft
NIDDK states that a fistula is the best long-term option because it is “less likely to become infected or clot”, that a graft has more problems with infection and clotting than a fistula, and that any access can become infected or clot or scar (read 2026-11-07). This is why NIDDK describes a catheter as a temporary access. Related infection prevention practice is covered in the CLABSI prevention bundle and the general central venous catheter guide.
Hemodialysis catheter versus peritoneal dialysis catheter
A peritoneal dialysis (PD) catheter is a different device. NIDDK says a surgeon places it through a small incision, usually below or beside the navel, into the abdominal (peritoneal) cavity, under general or local anesthesia, and most people go home the same day. NIDDK advises planning placement at least 3 weeks before the first exchange, with 10 to 20 days of healing (read 2026-11-07). For the drain tube itself see peritoneal drain. For another long-term tunnelled catheter used for different purposes, see Broviac catheter.
How long do peritoneal dialysis catheters last?
NIDDK’s patient guidance does not give a fixed lifespan for a PD catheter. It describes only the 10 to 20 day healing period before use and the daily care of the exit site. Lifespan questions belong with the patient’s dialysis team.
Care basics for any dialysis catheter
General guidance from NIDDK for PD catheters: wash hands, clean the exit site daily as the care team instructs, wear a mask when connecting, and seek care for redness, pus or swelling. Hemodialysis catheter site care is taught by the patient’s own dialysis unit and follows the unit’s protocol.
Common mistakes to avoid
- Treating “Permcath”, “permacath” and a brand name as different regulatory categories. The FDA classes devices by function and duration.
- Assuming a catheter is a permanent solution. Published case reports describe risks of long-term tunnelled catheters, including a catheter becoming adherent to central veins after prolonged use (BMC Nephrology, PMID 38500070).
- Mixing up hemodialysis and peritoneal dialysis catheters, which are placed in different locations and used differently.
Frequently asked questions
Can a Permacath be removed?
Yes, catheters are removed by clinicians when they are no longer needed. A BMC Nephrology case report notes that tunnelled cuffed catheters left in place for a prolonged period can become fixed by fibrous adhesion to the central veins, in which case standard bedside removal by dissecting the cuff may not be enough and interventional radiology may be needed (PMID 38500070). Removal is a clinician’s decision and procedure, and this page does not give steps.
What does “tunnelled” mean here?
It describes a catheter that runs under the skin before entering a vein. The cuff in the regulation’s “catheters with cuff(s)” example is part of that long-term design. The FDA text itself does not use the word “tunnelled”.
Sources
- FDA, 21 CFR 876.5540, Blood access device and accessories (eCFR, read 2026-11-07).
- NIDDK, Hemodialysis, niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis (read 2026-11-07).
- NIDDK, Peritoneal Dialysis, niddk.nih.gov/health-information/kidney-disease/kidney-failure/peritoneal-dialysis (read 2026-11-07).
- BD, GlidePath Long-Term Hemodialysis Catheters product page (read 2026-11-07).
- Burnett C et al. The stuck haemodialysis catheter. BMC Nephrol 2024;25:104. PMID 38500070.
- Chambi-Torres JB et al. Fibrin sheath catheter-related endovascular right-sided heart infection. Cureus 2023;15(6):e40060. PMID 37425584.







